Google
×
Mar 15, 2023 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
We have applied to list our common stock on the Nasdaq Global Market under the symbol “RXDX.” We are an “emerging growth company” under applicable Securities ...
RXDX SEC Filings - Prometheus Biosciences Inc- Annual Report, Proxy Statement, Prospectus. ... investor presentations (found in 8Ks), insider trades (form 4) ...
Prometheus Biosciences (RXDX) stock investors activity – investors allocate an average of 3.54% to RXDX, based on 666590 active investor portfolios.
Missing: relations | Show results with:relations
EX-99 2 rxdx-ex99_1.htm EX-99.1 ... (Nasdaq: RXDX), a clinical-stage biotechnology ... 740,773. $. 267,801. Contacts: Noel Kurdi. VP Investor Relations and ...
People also ask
Prometheus Biosciences Inc (US:RXDX) has 7 institutional owners and shareholders ... investor may file a 13D ... Reports First Quarter 2023 Financial Results and ...
Apr 16, 2023 · Merck will hold an investor call on Monday, April 17, at 8:00 a.m. EDT to discuss this proposed acquisition. Journalists who wish to ask ...
No information is available for this page. · Learn why
Jun 15, 2023 · At a special meeting to be held on June 15, 2023, the shareholders of Prometheus Biosciences, Inc. (RXDX) approved the merger with Merck ...
Missing: investor relations
Apr 17, 2023 · RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today.